Dr. Reddy's Gets EIR from USFDA for UK Plant
Dr. Reddy’s Laboratories has received an establishment inspection report (EIR) from the US health regulator after audit of its UK API facility. “With regard to the audit of our API Mirfield plant, United Kingdom, we would now like to inform that we have received an establishment inspection report (EIR) from the USFDA, indicating closure of the audit,” Dr. Reddy’s said in a regulatory filing. The USFDA issues an EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection. In September last year, the US health regulator had made three observations after inspecting the API Mirfield plant.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EPA Pressures Minnesota to Tackle Nitrate Threat in Drinking Water
-
FDA Proposes Nationwide Ban on Brominated Vegetable Oil (BVO) in Food Additives, Continues Safety Assessment of Chemicals
-
USDA-FSIS Initiates Year-Long Survey of Dioxins in Cattle, Swine, and Catfish Starting November
-
New Advance Notification Guidelines for Imported Foods Released by the United States
-
The world's first octreotide capsule was approved by the FDA!
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
FDA Fast-Tracks U.S. Drug Manufacturing
Recommend Reading
-
![FDA Warning Letters Put GMP Back in Focus]()
FDA Warning Letters Put GMP Back in Focus
-
![Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm]()
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
![Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger]()
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
![China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot]()
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
![Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire]()
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
![Ethanol Market Prices Show Slight Fluctuations]()
Ethanol Market Prices Show Slight Fluctuations
-
![This Week's Styrene Market Slightly Declined (4.13-4.17) in China]()
This Week's Styrene Market Slightly Declined (4.13-4.17) in China
-
![BDO Market Conditions Remain Weak]()
BDO Market Conditions Remain Weak
-
![Off-season Supply Increases, Polyethylene Continues Downward Trend in China]()
Off-season Supply Increases, Polyethylene Continues Downward Trend in China
-
![Business Society’s PVC Market Outlook on August 11, 2026: Stable with a Slight Rise]()
Business Society’s PVC Market Outlook on August 11, 2026: Stable with a Slight Rise
